Skip to content

Regulatory Press Releases

PILA PHARMA AB APPOINTS NEW CHAIRMAN OF THE BOARD AND CEO

Malmö, 19 april 2024 Download the press release as PDF here Following the election yesterday of Dorte X. Gram as new Chairman of the Board of Pila Pharma AB (publ) (FN STO: PILA) she simultaneously has stepped down as CEO. The newly elected Board of Directors has subsequently appointed Gustav H. Gram as new CEO and Dorte X. Gram as Chief…

Read more

KOMMUNIKE FRÅN ÅRSSTÄMMA I PILA PHARMA AB 2024

Malmö, 18 april 2024 Download the press release as PDF here Pila Pharma AB (publ) höll på torsdagen den 18 april 2024 årsstämma hos MAQS Advokatbyrå, Gibraltargatan 7 i Malmö. Följande huvudsakliga beslut fattades:  Fastställande av resultat- och balansräkningarÅrsstämman fastställde bolagets resultat- och balansräkning för räkenskapsåret 2023. ResultatdispositionÅrsstämman beslutade att ingen utdelning ska lämnas för räkenskapsåret 2023. Beslut om ansvarsfrihetÅrsstämman beviljade…

Read more

KALLELSE TILL ÅRSSTÄMMA I PILA PHARMA AB

Malmö i mars 2024 Download the press release as PDF here Aktieägarna i PILA PHARMA AB, org.nr 556966-4831 ("PILA PHARMA" eller "Bolaget"), kallas härmed till årsstämma tisdag den 18 april 2024 kl. 15.00 hos MAQS Advokatbyrå, Gibraltargatan 7 i Malmö. Registrering till stämman börjar kl. 14.30. Anmälan Aktieägare, som önskar delta vid årsstämman, ska (i) dels vara införd i den av Euroclear Sweden…

Read more

PILA PHARMA PUBLISHES THE ANNUAL REPORT 2023

Malmö, 20 March 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) announces that the annual report (in Swedish) is now available on the Company´s homepage, https://pilapharma.com/investors/finansiell-information/, and as an attachment to this press release. " The year 2023 was when the global interest in treatments of obesity became a megatrend! This is interesting for…

Read more

PILA PHARMA ADVANCES THE PUBLICATION OF THE ANNUAL REPORT 2023

Malmö, 20 March 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) has decided to advance the publication of its annual report for the financial year ended 31 December 2023 to the 20 March 2024. The previous date for the publication of the annual report for the financial year ended 31 December 2023 was…

Read more
Back To Top